<DOC>
	<DOCNO>NCT00529633</DOCNO>
	<brief_summary>Both malnutrition inflammation associate death dialysis patient also cardiovascular disease . The researcher test idea inflammation cause malnutrition use drug suppress inflammation hemodialysis patient find whether increase blood test associate malnutrition . The researcher give hemodialysis patient inflammation malnutrition either thalidomide placebo compare effect treatment level two protein blood , albumin prealbumin , normally reduce malnourished patient . Patients serum albumin concentration &lt; 3.8 g/dl ask sign consent blood drawn prior dialysis measurement CRP ( C-reactive protein ) . Those CRP value ≥ 0.8 mg/dl second measurement CRP perform within 2 week . Those two consecutive value CRP ≥ 0.8 mg/dl eligible enrollment</brief_summary>
	<brief_title>The Effect Thalidomide Suppression Systemic Inflammatory Response Syndrome Hemodialysis Patients</brief_title>
	<detailed_description>4.1 Pre-assignment measurement include : 1 . Patient eligible enrollment . 2 . Complete physical examination . 3 . Blood draw initiation hemodialysis session 4 . Instruction birth control method require . 5 . Subjects non-compliant regard medication compliance range birth control requirement outline S.T.E.P.S.® program immediately discontinue study 4.2 Detailed description treatment : Patients complete first 4 week randomize Treatment group . A total 24 subject study ; 12 receive drug 12 receive thalidomide . Subjects randomize `` Active '' Treatment arm receive Placebo ( no-drug/sugar pill ) , thalidomide 100 mg ( two 50 mg active capsule ) take bedtime . Weekly , Subjects blood drawn ; undergo capsule count establish compliance range &gt; 85 % ; physical exam special attention skin evaluation peripheral nervous system change appearance sensory neuropathy . If somnolence tolerable ( subject residual somnolence morning ) dose increase 200 mg ( 4 capsule ) . Patients complete 24 week study final evaluation week 28 .</detailed_description>
	<mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
	<mesh_term>Hypoalbuminemia</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>1 . End stage renal disease ( ESRD ) patient hemodialysis least 3 month . 2 . Serum C reactive protein level ≥ 0.8 mg/dl . 3 . Serum albumin &lt; 3.8 g/dl ( BCG ) . 4 . Signing write informed consent form . 5 . Willingness ability comply FDAmandated S.T.E.P.S ® program . 6 . Age &gt; 18 year . 1 . Pregnant and/ lactate female . 2 . Active infection within previous 8 week require administration antibiotic . 3 . Patients receive systemic immunosuppressive therapy . 4 . Patients HIV .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Inflammation</keyword>
	<keyword>albumin</keyword>
</DOC>